The present invention relates to novel fluorinated piperidine derivatives having antagonistic activity at the 5-HT2B receptor, pharmaceutical compositions comprising these compounds and their use as a medicine in the treatment or prevention of pulmonary arterial hypertension, pulmonary fibrosis or irritable bowel syndrome.
本发明涉及新型
氟代
哌啶衍
生物,具有5-HT2B受体拮抗活性,包括这些化合物的制药组合物,以及它们作为药物治疗或预防肺动脉高压、肺纤维化或肠易激综合征的用途。